OS Therapies Incorporated (OSTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $34.87M
Last updated: Nov 17, 2026 at 11:05 AM ET
OS Therapies Incorporated (OSTX) Earnings: Report Dates and Results
In the quarter ended Jun 30, 2026, OS Therapies reported EPS of -$0.20, above the -$0.25 estimate. It beat the EPS estimate in 1 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OSTX's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 8 quarters below that had an estimate, OSTX beat 1 and missed 7. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 192.86% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.20 | -$0.25 | -$0.27 - -$0.19 | +20.00% | Beat | N/A | 3 | 0 up, 1 down | Aug 14, 2026 |
| Mar 31, 2026 | -$0.27 | -$0.19 | -$0.19 - -$0.19 | -42.11% | Miss | N/A | 2 | 0 up, 0 down | May 18, 2026 |
| Dec 31, 2025 | -$0.41 | -$0.14 | -$0.22 - -$0.06 | -192.86% | Miss | N/A | 4 | 1 up, 1 down | Mar 31, 2026 |
| Sep 30, 2025 | -$0.21 | -$0.12 | -$0.18 - -$0.07 | -75.00% | Miss | N/A | 4 | 0 up, 2 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.19 | -$0.15 | -$0.16 - -$0.04 | -26.67% | Miss | N/A | 3 | 0 up, 1 down | Aug 19, 2025 |
| Mar 31, 2025 | -$0.18 | -$0.11 | N/A | -63.64% | Miss | N/A | N/A | N/A | May 15, 2025 |
| Dec 31, 2024 | -$0.19 | -$0.14 | N/A | -35.71% | Miss | N/A | 2 | 0 up, 0 down | Mar 31, 2025 |
| Sep 30, 2024 | -$0.18 | -$0.08 | -$0.16 - -$0.08 | -125.00% | Miss | N/A | 2 | 0 up, 0 down | Nov 15, 2024 |
| Jun 30, 2024 | -$0.61 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2024 |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$0.47 | N/A |
| Jun 30, 2026 | -$0.47 | N/A |
| Dec 31, 2025 | -$0.99 | N/A |
| Jun 30, 2025 | -$0.37 | N/A |
| Dec 31, 2024 | -$0.98 | N/A |
Frequently Asked Questions About OSTX
Did OSTX beat earnings estimates last quarter?
Yes. OS Therapies reported EPS of -$0.20 for the quarter ended Jun 30, 2026, above the -$0.25 estimate, a 20.00% surprise.
What EPS do analysts expect from OSTX next quarter?
The consensus EPS estimate for OS Therapies for the quarter ending Dec 31, 2026 is -$0.16 from 6 analysts, with estimates from -$0.20 to -$0.11.
How often does OSTX beat earnings estimates?
OS Therapies beat the EPS estimate in 1 of the last 8 quarters, with an average surprise of -67.62%.
OSTX pages: Overview, Earnings, Forecast, Financials, Competitors